(Q39969906)

English

Ag-specific type 1 CD8 effector cells enhance methotrexate-mediated antitumor responses by modulating endogenous CD49b-expressing CD4 and CD8 T effector cell subpopulations producing IL-10.

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Ag-specific type 1 CD8 effector cells enhance methotrexate-mediated antitumor responses by modulating endogenous CD49b-expressing CD4 and CD8 T effector cell subpopulations producing IL-10. (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

author name string

Mark J Dobrzanski

1

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Joyce B Reome

2

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

James C Hylind

3

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Kathleen A Rewers-Felkins

4

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Khaliquzzaman Abdulsamad

5

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Shawna L Adams

6

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

publication date

1 January 2008

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Immunological Investigations

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

37

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

315-338

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Homeostasis of T cell numbers: from thymus production to peripheral compartmentalization and the indexation of regulatory T cells

1 reference

https://api.crossref.org/works/10.1080%2F08820130802083762

21 January 2018

Cutting edge: the mouse NK cell-associated antigen recognized by DX5 monoclonal antibody is CD49b (alpha 2 integrin, very late antigen-2)

1 reference

https://api.crossref.org/works/10.1080%2F08820130802083762

21 January 2018

In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines.

1 reference

https://api.crossref.org/works/10.1080%2F08820130802083762

21 January 2018

Allogeneic lymphocytes induce tumor regression of advanced metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1080%2F08820130802083762

21 January 2018

Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death

1 reference

https://api.crossref.org/works/10.1080%2F08820130802083762

21 January 2018

Timeline: Chemotherapy and the war on cancer.

1 reference

https://api.crossref.org/works/10.1080%2F08820130802083762

21 January 2018

Resurrecting CD8+ suppressor T cells

1 reference

https://api.crossref.org/works/10.1080%2F08820130802083762

21 January 2018

Generation of polarized antigen-specific CD8 effector populations: reciprocal action of interleukin (IL)-4 and IL-12 in promoting type 2 versus type 1 cytokine profiles

1 reference

https://api.crossref.org/works/10.1080%2F08820130802083762

21 January 2018

Differential antitumor immunity mediated by NKT cell subsets in vivo

1 reference

https://api.crossref.org/works/10.1080%2F08820130802083762

21 January 2018

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

1 reference

https://api.crossref.org/works/10.1080%2F08820130802083762

21 January 2018

Tc1 and Tc2 effector cell therapy elicit long-term tumor immunity by contrasting mechanisms that result in complementary endogenous type 1 antitumor responses

1 reference

https://api.crossref.org/works/10.1080%2F08820130802083762

21 January 2018

CD8-mediated type 1 antitumor responses selectively modulate endogenous differentiated and nondifferentiated T cell localization, activation, and function in progressive breast cancer

1 reference

https://api.crossref.org/works/10.1080%2F08820130802083762

21 January 2018

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

1 reference

https://api.crossref.org/works/10.1080%2F08820130802083762

21 January 2018

Cutting edge: CD8+CD122+ regulatory T cells produce IL-10 to suppress IFN-gamma production and proliferation of CD8+ T cells.

1 reference

https://api.crossref.org/works/10.1080%2F08820130802083762

21 January 2018

Natural killer cells actively patrol peripheral lymph nodes forming stable conjugates to eliminate MHC-mismatched targets

1 reference

https://api.crossref.org/works/10.1080%2F08820130802083762

21 January 2018

NKT cells: what's in a name?

1 reference

https://api.crossref.org/works/10.1080%2F08820130802083762

21 January 2018

A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis

1 reference

https://api.crossref.org/works/10.1080%2F08820130802083762

21 January 2018

The pharmacology and clinical use of methotrexate

1 reference

https://api.crossref.org/works/10.1080%2F08820130802083762

21 January 2018

Distinct NKT cell subsets are induced by different Chlamydia species leading to differential adaptive immunity and host resistance to the infections

1 reference

https://api.crossref.org/works/10.1080%2F08820130802083762

21 January 2018

Signal transduction from the extracellular matrix

1 reference

https://api.crossref.org/works/10.1080%2F08820130802083762

21 January 2018

5-Fluorouracil: mechanisms of action and clinical strategies

1 reference

https://api.crossref.org/works/10.1080%2F08820130802083762

21 January 2018

Integrin-mediated ras-extracellular regulated kinase (ERK) signaling regulates interferon gamma production in human natural killer cells

1 reference

https://api.crossref.org/works/10.1080%2F08820130802083762

21 January 2018

Tumors as elusive targets of T-cell-based active immunotherapy

1 reference

https://api.crossref.org/works/10.1080%2F08820130802083762

21 January 2018

Sensitization of cancer cells treated with cytotoxic drugs to fas-mediated cytotoxicity.

1 reference

https://api.crossref.org/works/10.1080%2F08820130802083762

21 January 2018

Drug penetration in solid tumours

1 reference

https://api.crossref.org/works/10.1080%2F08820130802083762

21 January 2018

Immune suppression and skin cancer development: regulation by NKT cells.

1 reference

https://api.crossref.org/works/10.1080%2F08820130802083762

21 January 2018

Interleukin-10 and the interleukin-10 receptor

1 reference

https://api.crossref.org/works/10.1080%2F08820130802083762

21 January 2018

TS/A: a new metastasizing cell line from a BALB/c spontaneous mammary adenocarcinoma

1 reference

https://api.crossref.org/works/10.1080%2F08820130802083762

21 January 2018

DX5/CD49b-Positive T Cells Are Not Synonymous with CD1d-Dependent NKT Cells

1 reference

https://api.crossref.org/works/10.1080%2F08820130802083762

21 January 2018

Naturally-occurring CD4+CD25+ immunoregulatory T cells: central players in the arena of peripheral tolerance

1 reference

https://api.crossref.org/works/10.1080%2F08820130802083762

21 January 2018

Building better vaccines: how apoptotic cell death can induce inflammation and activate innate and adaptive immunity

1 reference

https://api.crossref.org/works/10.1080%2F08820130802083762

21 January 2018

Shedding light on immunotherapy for cancer

1 reference

https://api.crossref.org/works/10.1080%2F08820130802083762

21 January 2018

Cytokine-induced differentiation of precursor mouse CD8+ T cells into cytotoxic CD8+ T cells secreting Th1 or Th2 cytokines.

1 reference

https://api.crossref.org/works/10.1080%2F08820130802083762

21 January 2018

Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones

1 reference

https://api.crossref.org/works/10.1080%2F08820130802083762

21 January 2018

Apoptotic, but not necrotic, tumor cell vaccines induce a potent immune response in vivo

1 reference

https://api.crossref.org/works/10.1080%2F08820130802083762

21 January 2018

Integrins: emerging paradigms of signal transduction

1 reference

https://api.crossref.org/works/10.1080%2F08820130802083762

21 January 2018

Molecular identification of a danger signal that alerts the immune system to dying cells

1 reference

https://api.crossref.org/works/10.1080%2F08820130802083762

21 January 2018

Stroma is critical for preventing or permitting immunological destruction of antigenic cancer cells

1 reference

https://api.crossref.org/works/10.1080%2F08820130802083762

21 January 2018

New aspects of natural-killer-cell surveillance and therapy of cancer

1 reference

https://api.crossref.org/works/10.1080%2F08820130802083762

21 January 2018

CD4+CD25+ T regulatory cells suppress NK cell-mediated immunotherapy of cancer

1 reference

https://api.crossref.org/works/10.1080%2F08820130802083762

21 January 2018

Regulation of mature T cell homeostasis

1 reference

https://api.crossref.org/works/10.1080%2F08820130802083762

21 January 2018

IL-10-secreting regulatory T cells do not express Foxp3 but have comparable regulatory function to naturally occurring CD4+CD25+ regulatory T cells

1 reference

https://api.crossref.org/works/10.1080%2F08820130802083762

21 January 2018

Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells

1 reference

https://api.crossref.org/works/10.1080%2F08820130802083762

21 January 2018

Melanocyte destruction after antigen-specific immunotherapy of melanoma: direct evidence of t cell-mediated vitiligo.

1 reference

https://api.crossref.org/works/10.1080%2F08820130802083762

21 January 2018

Immature Dendritic Cells Suppress Collagen-Induced Arthritis by In Vivo Expansion of CD49b+ Regulatory T Cells

1 reference

https://api.crossref.org/works/10.1080%2F08820130802083762

21 January 2018

Predominant Th2/Tc2 Polarity of Tumor-Infiltrating Lymphocytes in Human Cervical Cancer

1 reference

https://api.crossref.org/works/10.1080%2F08820130802083762

21 January 2018

Chemoimmunotherapy of Tumors: Cyclophosphamide Synergizes with Exosome Based Vaccines

1 reference

https://api.crossref.org/works/10.1080%2F08820130802083762

21 January 2018

Identifiers

10.1080/08820130802083762

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39969906&oldid=1476355280"